4.5 Article

Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver Disease

Marc-Olivier Deguise et al.

Summary: The Smn(2B/-) mouse model rapidly develops microvesicular steatohepatitis, providing an opportunity to study the pathogenesis of NAFLD. While not a typical NAFLD/NASH model, it offers a reliable, low-cost, and early-onset model for both adult and pediatric populations.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Neurosciences

Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit

Meaghan Van Alstyne et al.

Summary: This study demonstrates that long-term use of AAV9-SMN gene therapy in mice can lead to motor dysfunction and neuronal loss through protein aggregation. Overexpression of SMN interferes with RNA regulation and triggers SMA-like pathogenic events through toxic gain-of-function mechanisms. These findings suggest caution in the long-term safety of treating individuals with SMA with AAV9-SMN.

NATURE NEUROSCIENCE (2021)

Article Pediatrics

Nusinersen for spinal muscular atrophy type 1: Real-world respiratory experience

Moran Lavie et al.

Summary: The study reported respiratory outcomes of 20 SMA1 patients treated with Nusinersen in real-world settings. Most patients remained stable in their need for respiratory support, but some experienced acute respiratory failure leading to death or severe brain injury.

PEDIATRIC PULMONOLOGY (2021)

Article Clinical Neurology

Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen

Claudia D. Wurster et al.

JOURNAL OF NEUROLOGY (2020)

Article Biotechnology & Applied Microbiology

AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice

Aurore Besse et al.

MOLECULAR THERAPY (2020)

Article Medicine, General & Internal

Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy

Marc-Olivier Deguise et al.

EBIOMEDICINE (2020)

Article Clinical Neurology

Abnormal fatty acid metabolism is a core component of spinal muscular atrophy

Marc-Olivier Deguise et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Anatomy & Morphology

Survival of motor neurone protein is required for normal postnatal development of the spleen

Alison K. Thomson et al.

JOURNAL OF ANATOMY (2017)

Article Medicine, General & Internal

Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

J. R. Mendell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Correction Biochemistry & Molecular Biology

SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice (vol 24, pg 3847, 2015)

Sara E. Gombash et al.

HUMAN MOLECULAR GENETICS (2015)

Article Clinical Neurology

Spinal Muscular Atrophy

Stephen J. Kolb et al.

NEUROLOGIC CLINICS (2015)

Article Biochemistry & Molecular Biology

Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy

Justin G. Boyer et al.

HUMAN MOLECULAR GENETICS (2014)

Article Biochemistry & Molecular Biology

Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics

Katherine V. Bricceno et al.

HUMAN MOLECULAR GENETICS (2014)

Article Clinical Neurology

Glucose metabolism and pancreatic defects in spinal muscular atrophy

Melissa Bowerman et al.

ANNALS OF NEUROLOGY (2012)

Article Clinical Neurology

Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks

Zarazuela Zolkipli et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2012)

Article Biochemistry & Molecular Biology

Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice

Elisa Dominguez et al.

HUMAN MOLECULAR GENETICS (2011)

Article Biochemistry & Molecular Biology

Cardiac defects contribute to the pathology of spinal muscular atrophy models

Monir Shababi et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biotechnology & Applied Microbiology

Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

Kevin D. Foust et al.

NATURE BIOTECHNOLOGY (2010)

Article Cell Biology

Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy

Chiara F. Valori et al.

SCIENCE TRANSLATIONAL MEDICINE (2010)

Article Biotechnology & Applied Microbiology

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

Kevin D. Foust et al.

NATURE BIOTECHNOLOGY (2009)

Review Neurosciences

Tests to assess motor phenotype in mice: a user's guide

Simon P. Brooks et al.

NATURE REVIEWS NEUROSCIENCE (2009)

Article Genetics & Heredity

Congenital heart disease is a feature of severe infantile spinal muscular atrophy

S. Rudnik-Schoeneborn et al.

JOURNAL OF MEDICAL GENETICS (2008)

Article Clinical Neurology

Consensus statement for Standard of Care in Spinal Muscular Atrophy

Ching H. Wang et al.

JOURNAL OF CHILD NEUROLOGY (2007)

Article Biochemistry & Molecular Biology

An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN

CL Lorson et al.

HUMAN MOLECULAR GENETICS (2000)